1. Introduction {#sec1-ijerph-13-00516}
===============

Hyperlipidemia, a major systemic disorder, is an important modifiable risk factor for coronary heart disease and extra-coronary atherosclerosis \[[@B1-ijerph-13-00516],[@B2-ijerph-13-00516]\] and associated with a higher risk of cardiovascular disease (CVD), which is a leading contributor to mortality worldwide, particularly in China \[[@B3-ijerph-13-00516]\]. Estimates from the World Health Organization (WHO) suggested that CVDs contributed to approximately 17.5 million individuals deaths in 2012 \[[@B4-ijerph-13-00516]\].

Moreover, hyperlipidemia is commonly associated with obesity which is known as a risk factor for CVD \[[@B5-ijerph-13-00516],[@B6-ijerph-13-00516]\]. Converging lines of evidence suggests that hyperlipidemia is associated with a high BMI \[[@B7-ijerph-13-00516],[@B8-ijerph-13-00516]\]. Around 3.4 million adults deaths, 3.9% of years of life lost and 3.8% of disability-adjusted life-years (DALYs) each year worldwide, were attributed to overweight or obese \[[@B9-ijerph-13-00516]\]. BMI is currently the most widely used anthropometric measurement to predict health risk related to weight status, and a large number of studies have reported a significant relationship between BMI and hyperlipidemia \[[@B10-ijerph-13-00516]\]. However, previous studies converted BMI into categorical variables when performing the multivariate analysis.

In the present study, we examined the nonlinear dose-response relationship between the continuous variance of BMI and the prevalence of hyperlipidemia. As an intuitive method for presenting data, the restricted cubic spline has been widely used in the field of meta-analysis and other researches \[[@B11-ijerph-13-00516],[@B12-ijerph-13-00516],[@B13-ijerph-13-00516]\].

2. Experimental Section {#sec2-ijerph-13-00516}
=======================

2.1. Study Population {#sec2dot1-ijerph-13-00516}
---------------------

Our study was conducted in the framework of the Project on Present Situation and Change Forecast of Disease Spectrum in Jilin Province, China. It was supported by the Bureau of Public Health of Jilin Province, China. A total of 21,435 participants (community-dwelling residents aged 18 to 79 years) were enrolled from June 2012 to August 2012 and completed the survey. Subjects with incomplete blood lipid information were excluded. Our study adopted a multistage stratified cluster random sampling method, with the sample selected from all nine administrative regions in Jilin Province. The details of the sampling process were published elsewhere \[[@B14-ijerph-13-00516]\].

We stuck to the bioethics principles of the Declaration of Helsinki, and our study was authorized by the Ethics Committee of Jilin University School of Public Health (Reference Number: 2012-R-011) and the Bureau of Public Health of Jilin Province(Reference Number: 2012-10). All participants voluntarily joined this study with informed consents.

2.2. Data Collection and Measurements {#sec2dot2-ijerph-13-00516}
-------------------------------------

Our study adopted a structured pre-coded personal health survey questionnaire compiled by the Bureau of Public Health of Jilin Province united with the School of Public Health of Jilin University and the Jilin Disease Prevention and Control Information Platform. Participants were interviewed in a face-to-face manner by specially trained researchers. The collected information included demographic characteristics (region, age, gender, level of education and main occupation), lifestyles (smoking, drinking and exercise), history of hyperlipidemia in the past one year, and current treatment of hyperlipidemia.

In the light of the standard protocols and techniques, the participants went through anthropometric examinations including height, weight, waist, and hip circumference measurements by a trained certified research practitioner. Participants with light-colored clothing were measured for their weight as well as waist and hip circumference early in the morning after the food-intake. They were measured for heights after taking shoes off. Each physical measurement was completed by two research assistants.

Fasting venous blood samples of each participant were extracted by venipuncture for measuring the levels of blood lipids, including total cholesterol (TC), high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), and triglycerides (TG). Blood lipids were measured using the MODULE P800 automated biochemistry analyzer (ROCHE Diagnostics Ltd., Indianapoils, IN, USA) in a core laboratory with a standard protocol.

2.3. Definitions {#sec2dot3-ijerph-13-00516}
----------------

In terms of the Chinese guidelines on the prevention and treatment of dyslipidemia in adults (2007) \[[@B15-ijerph-13-00516]\], hyperlipidemia was defined as total cholesterol (TC ≥ 5.18 mmol/L), and/or low-density lipoprotein cholesterol (LDL-C ≥ 3.37 mmol/L), and/or high-density lipoprotein cholesterol (HDL-C \< 1.04 mmol/L), and/or triglycerides (TG ≥ 1.70 mmol/L), and/or with history of hyperlipidemia diseases in the past one year. BMI was defined as a person's weight in kilograms divided by the square of his/her height in meters (kg/m^2^). Our study categorized adults as: Underweight with BMI \< 18.5 kg/m^2^,normal weight with 18.5 ≤ BMI \< 24 kg/m^2^, overweight with 24 ≤ BMI \< 30 kg/m^2^,and obese with BMI ≥ 30 kg/m^2^ \[[@B16-ijerph-13-00516]\]. Central obesity was defined as the waist circumference ≥85 cm for man or ≥80 cm for woman \[[@B17-ijerph-13-00516]\]. The smoking status was categorized into current smoker (smoking at least 100 cigarettes in their lifetime and smoking daily or during the time of the survey), former smoker (smoking at least 100 cigarettes in their lifetime but not smoking at the time of the survey),and non-smoking (never smoked or smoked less than 100 cigarettes in their lifetime) \[[@B18-ijerph-13-00516]\]. A drinker was defined as a person who consumed more than one alcoholic drink weekly on average, either spirits, beer, wine, or other forms of alcohol. Participants who exercised one or two times a week were classified as "sometimes exercise"; those who exercised more than three times a week were classified as "often exercise"; and those who do not or seldom exercise were classified as "never or rarely exercise". Psychological distress was evaluated using the 12-item general health questionnaire (GHQ-12) which has been widely used in China \[[@B19-ijerph-13-00516]\]. All participants were sorted into two groups with a cut-point of 4 on a 0--12 point with those scoring 4 or more being deemed as being in psychological distress \[[@B20-ijerph-13-00516]\].

2.4. Statistical Analysis {#sec2dot4-ijerph-13-00516}
-------------------------

For database management and statistical analysis, we used the Epidata software (version 3.1, Odense, Denmark) and the SPSS software (version 21.0, IBM SPSS, IBM Corp., Armonk, NY, USA). The Kolmogorov-Smirnov test was used to analyze for normality. The distributions of demographic characteristics between participants with and without hyperlipidemia were calculated by Chi-square tests for categorical variables or computed by the Wilcoxon signed-rank test for continuous variables if not following normal distributions. We used the adjusted logistic regression model to individually analyze the correlations of BMI and hyperlipidemia and the restricted cubic spline method was evaluated a potential non-linear relationship between BMI and hyperlipidemia \[[@B21-ijerph-13-00516],[@B22-ijerph-13-00516],[@B23-ijerph-13-00516]\]. Restricted cubic spline was implemented by the Stata software (version 12.0, Stata Press, College Station, TX, USA).Variables that were statistically significant at *p* \< 0.05 level were entered into multivariate logistic regression analyses. All statistical tests were two-tailed and *p* \< 0.05 was considered statistically significant.

3. Results {#sec3-ijerph-13-00516}
==========

The prevalence of hyperlipidemia among residents on Jilin Province was 51.09% (10,951/21,435), with 52.04% in males and 50.21% in females. The prevalences of overweight and obesity were respectively 31.89% and 6.23%, with a slightly higher prevalence of both overweight and obesity in women than men (overweight:16.10% *vs.* 15.78%; obesity:3.28% *vs.* 2.95%).

[Table 1](#ijerph-13-00516-t001){ref-type="table"} shows demographic characteristics of participants. Hyperlipidemia was significantly correlated with gender (*p* = 0.007), region (*p* \< 0.001), district (*p* \< 0.001), ethnicity (*p* = 0.047), education (*p* \< 0.001), marital status (*p* \< 0.001), main occupation (*p* \< 0.001), monthly family income per capita (*p* \< 0.001), smoking (*p* \< 0.001), drinking (*p* \< 0.001), exercise (*p* \< 0.001), and central obesity (*p* \< 0.001). However, subjects with or without hyperlipidemia did not show significant differences in family history of hyperlipidemia and GHQ-12 (*p* \> 0.05). [Table 2](#ijerph-13-00516-t002){ref-type="table"} presents that the age, BMI, and waist and hip circumferences of participants with hyperlipidemia were significant higher than those without hyperlipidemia (all *p* \< 0.001).

As shown in [Table 3](#ijerph-13-00516-t003){ref-type="table"}, BMI levels were significantly associated with hyperlipidemia via unadjusted logistic regression (*p* \< 0.001). In the age- and gender-adjusted logistic regression, our survey observed that there was a significant correlation between different BMI ranges and hyperlipidemia (*p* \< 0.001). Underweight (OR = 0.729, 95% CI: 0.616--0.864) was associated with a lower prevalence of hyperlipidemia and overweight (OR = 1.651, 95% CI: 1.520--1.793), and obesity (OR = 1.714, 95% CI: 1.457--2.017) were independently associated with increased risks of hyperlipidemia (*p* \< 0.001) after adjustment for age, gender, region, district, ethnicity, education, marital status, main occupation, monthly family income per capita, smoking, drinking, exercise, central obesity, and waist and hip circumferences. In further analyses, we found a significant trend between BMI and the presence of hyperlipidemia in the univariate model, model I (adjusted age and gender), and model II (adjusted age, gender, region, district, ethnicity, education, marital status, main occupation, monthly family income per capita, smoking, drinking, exercise, central obesity, and waist and hip circumferences) (all *p* \< 0.001).

The fitted dose-response relationship is depicted in [Figure 1](#ijerph-13-00516-f001){ref-type="fig"}. Overall, we found a significant nonlinear dose-response association between BMI and risk of hyperlipidemia (*p* value for nonlinearity \<0.001) with a significantly increased trend of odds ratio as per 1 kg/m^2^ increase in BMI, adjusted for age, waist and hip circumferences, gender, ethnicity, education, smoking, drinking. When compared with the reference (median level of the normal BMI range, approximately BMI = 23 kg/m^2^), the ORs (95% CI) for hyperlipidemia risks were 0.36 (0.33--0.40) for BMI at 18 kg/m^2^, 1.55 (1.49--1.61) for BMI at 25 kg/m^2^, and 2.57 (2.37--2.79) for BMI at 30 kg/m^2^, indicating a significant and progressive risk of hyperlipidemia along with BMI increases.

4. Discussion {#sec4-ijerph-13-00516}
=============

Our study showed that there was a significant correlation between different BMI ranges and hyperlipidemia (*p* \< 0.001). Overweight (OR = 1.651, 95% CI: 1.520--1.793), and obesity (OR = 1.714, 95% CI: 1.457--2.017) were independently associated with increased risks of hyperlipidemia (*p* \< 0.001) after adjustment for confounding factors. Furthermore, the dose--response analysis indicated a significant nonlinear association between BMI and the risk of hyperlipidemia, with a significantly increased trend of odds ratio as per 1 kg/m^2^ increase in BMI. The ORs (95% CI) for hyperlipidemia risks were 0.36 (0.33--0.40) for BMI at 18 kg/m^2^, 1.55 (1.49--1.61) for BMI at 25 kg/m^2^, and 2.57 (2.37--2.79) for BMI at 30 kg/m^2^, indicating a significant and progressive risk of hyperlipidemia along with BMI increases.

To our knowledge, this is the first report concerning the prevalence of hyperlipidemia in Jilin Province, northeast China. The prevalence of hyperlipidemia estimated by our study (total: 51.09%; females: 50.21%; males: 52.04%) was comparable to figures reported in published studies \[[@B24-ijerph-13-00516]\]. A previous study using data from administrative officers, who took part in annual regular physical examination from 1 September to 30 November in 1999, reported that the prevalence of hyperlipidemia in Shanghai among participants was 28.9% \[[@B25-ijerph-13-00516]\]. Considering that Shanghai is the biggest economic center of China, and one of the richest regions in China, the results of the study conducted with subjects from Shanghai may not be consistent with those from other studies. Compared to studies that examined the prevalence of hyperlipidemia among subjects from the Southwestern China, our results were similar with that reported by Deng *et al.* \[[@B26-ijerph-13-00516]\] (the prevalence of hyperlipidemia: 49.3%), but contradicted with the result of the study conducted by Yin *et al.* \[[@B27-ijerph-13-00516]\], who reported that the prevalence of hyperlipidemia was 35.91% in the Guangxi Zhuang Autonomous Region. Due to the inequality of development and large differences in lifestyles among subjects from different regions of China, the prevalence of hyperlipidemia may have contradictory results. Given that the diet of Chinese people in northeast China, with high salt and high fat content, is different from other parts of the Chinese population, our findings will be meaningful, and enable us to provide a theoretical basis when the government departments make relevant policies.

As we know, modification of excessive body weight (BMI of 27 or higher) is associated with a decreased risk of hyperlipidemia \[[@B28-ijerph-13-00516]\]. However, it is unclear whether the relationship between BMI and hyperlipidemia presented in a nonlinear trend, such as a U shaped pattern which was recognized between sleep duration and the risk of type 2 diabetes \[[@B29-ijerph-13-00516]\]. The present study demonstrated a nonlinear dose-response relationship between BMI and hyperlipidemia. The dose-response relationship has been reported in many studies \[[@B30-ijerph-13-00516]\]. For example, Friedrich *et al.* \[[@B31-ijerph-13-00516]\] reporteda U-shaped relationship between serum ferritin levels and the risk of CVD as well as IHD in women. Weiner *et al.* \[[@B32-ijerph-13-00516]\] also reported such a relationship between each of the non-traditional risk factor and outcomes using restricted cubic splines with four knots generated using S-Plus.

With the rapid economic development and urbanization process in China, the Chinese people have been experiencing tremendous nutritional transition and a big change in lifestyles \[[@B33-ijerph-13-00516]\]. Meanwhile, serum total cholesterol (TC) and low-density lipoprotein (LDL) levels of the Chinese peoplehave gradually increased in the past 10 years \[[@B34-ijerph-13-00516]\]. Therefore, our findings may have public health implications. Since obesity (BMI is 30 or higher) is an independent risk factor of hyperlipidemia, the intervention for obesity is very necessary for the Chinese people. It is well-known that healthy diets and physical activities are key to controlling the occurrence of obesity and hyperlipidemia. Therefore, we should adopt necessary measures such as replacing trans fats with unsaturated fats, implementing public awareness programs on diet and physical activity, and increasing the consumption of fruits and vegetables, to reduce trends in BMI and serum cholesterol. Furthermore, the Chinese government should pay attention to lipid-related diseases, increase investment for obesity and hyperlipidemia research, strengthen the primary health care system, inform the harm of the lipid-related disease and perform hyperlipidemia prevention and treatment \[[@B35-ijerph-13-00516]\].

Our study was subject to the following potential limitations. First, the cross-sectional nature of our study design may not allow us draw definite conclusions about a cause-and-effect relationship. However, since lifestyle behaviors and demographic characteristics for our respondents were relatively stable, our results should be considered to be reliable for policy-making. Second, due to the fact that our study did not take into account the study's complex sampling design, our samples were not representative of adults (aged 18 to 79 years) of Jilin Province in 2012. Therefore, our results merely reflected the relationship between BMI and hyperlipidemia. Finally, our study design adapted the WHO standard of BMI classification rather than the Chinese standard, which enables us to compare with the results of other studies.

5. Conclusions {#sec5-ijerph-13-00516}
==============

The results from the present study suggest that the continuous variance of BMI is significantly associated with the prevalence of hyperlipidemia. Particularly, our study indicates a dose-response nonlinear relationship between BMI and hyperlipidemia, with a significantly increased trend of odds ratio as per 1 kg/m^2^ increase in BMI. Our findings may guide the government in developing approaches to prevent hyperlipidemia and improving the healthy lifestyles of people.
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###### 

Demographic characteristics of adult samples (*n* = 21,435).

  Variable                       *n*      Hyperlipidemia   Non-Hyperlipidemia   *χ*^2^   *p*               
  ------------------------------ -------- ---------------- -------------------- -------- ------ ---------- ---------
  Gender                                                                                        7.166      0.007
  Female                         11,098   5572             50.9                 5526     52.7              
  Male                           10,337   5379             49.1                 4958     47.3              
  Region                                                                                        18.788     \<0.001
  Urban                          11,152   5539             50.6                 5613     53.5              
  Rural                          10,283   5412             49.4                 4871     46.5              
  District                                                                                      136.344    \<0.001
  Middle                         13,322   6433             58.7                 6889     65.7              
  East                           4104     2171             19.8                 1933     18.4              
  West                           4009     2347             21.4                 1662     15.9              
  Ethnicity                                                                                     3.950      0.047
  Han                            19,865   10,111           92.3                 9754     93.0              
  Other                          1570     840              7.7                  730      7.0               
  Education                                                                                     134.481    \<0.001
  Primary school or below        6236     3440             31.4                 2796     26.7              
  Junior high school             6125     3069             28.0                 3056     29.1              
  Senior high school             5559     2921             26.7                 2638     25.2              
  College and above              3515     1521             13.9                 1994     19.0              
  Marital status                                                                                455.081    \<0.001
  Married or cohabit             18,316   9613             87.8                 8703     83.0              
  Never married                  1693     470              4.3                  1223     11.7              
  Divorced                       388      201              1.8                  187      1.8               
  Widowed                        1038     667              6.1                  371      3.5               
  Main occupation                                                                               425.563    \<0.001
  Unemployed                     2653     1482             13.5                 1171     11.2              
  Mental workers                 4369     1973             18.0                 2396     22.9              
  Manual workers                 12,046   5858             53.5                 6188     59.0              
  Retired                        2367     1638             15.0                 729      7.0               
  Average monthly earnings ^a^                                                                  59.992     \<0.001
  \<500                          4304     2350             21.5                 1954     18.6              
  500\~                          3959     2059             18.8                 1900     18.1              
  1000\~                         7049     3628             33.1                 3421     32.6              
  2000\~                         3983     1945             17.8                 2038     19.4              
  3000\~                         2140     969              8.8                  1171     11.2              
  Smoking                                                                                       99.722     \<0.001
  Never smoked                   12,992   6307             57.6                 6685     63.8              
  Former smoker                  6723     3628             33.1                 3095     29.5              
  Current smoker                 1720     1016             9.3                  704      6.7               
  Drinking                                                                                      15.127     \<0.001
  No                             14,607   7330             66.9                 7277     69.4              
  Yes                            6828     3621             33.1                 3207     30.6              
  Exercise                                                                                      165.482    \<0.001
  Often                          6386     3689             33.7                 2697     25.7              
  Sometimes                      5220     2467             22.5                 2753     26.3              
  Never or rarely                9829     4795             43.8                 5034     48.0              
  Central obesity                                                                               1730.612   \<0.001
  No                             10,766   3978             36.3                 6788     64.7              
  Yes                            10,669   6973             63.7                 3696     35.3              
  Family history ^b^                                                                            2.202      0.138
  No                             20,494   10,448           95.4                 10,046   95.8              
  Yes                            941      503              4.6                  438      4.2               
  GHQ-12                                                                                        0.586      0.444
  No distress                    16,356   8380             76.5                 7976     76.1              
  Distress                       5079     2571             23.5                 2508     23.9              
  Diabetes                                                                                                 
  No                             19,479   9480             86.6                 9999     95.4   500.924    \<0.001
  Yes                            1956     1471             13.4                 485      4.6               
  Hypertension                                                                                             
  No                             13,924   5936             54.2                 7988     76.2   1137.581   \<0.001
  Yes                            7511     5015             45.8                 2496     23.8              

^a^ means monthly family income per capita; ^b^ means family history of hyperlipidemia.
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###### 

Distribution of age, BMI, waist and hip circumferences between participants with and without hyperlipidemia ((*n* = 21,435), M (Q~1~--Q~3~)).

  Variable        Hyperlipidemia (*n* = 10,951)   Non-Hyperlipidemia (*n* = 10,484)   Z         *p*
  --------------- ------------------------------- ----------------------------------- --------- ---------
  Age (years)     51 (42--59)                     43 (33--53)                         −37.421   \<0.001
  BMI (kg/m^2^)   25.029 (22.823--27.3995)        22.977 (20.727--25.044)             −42.684   \<0.001
  Waist (cm)      85.300 (79.000--92.000)         79.000 (72.000--85.000)             −46.686   \<0.001
  Hip (cm)        96.000 (92.000--101.000)        94.000 (89.000--97.475)             −29.716   \<0.001

ijerph-13-00516-t003_Table 3

###### 

Logistic regression analyses of the influence of BMI on hyperlipidemia prevalence.

  Model          BMI      B ^c^    S.E. ^d^   Wald       *p*                                OR (95% CI)
  -------------- -------- -------- ---------- ---------- ---------------------------------- ----------------------
  Univariate     \<18.5   −0.792   0.078      104.196    \<0.001                            0.453 (0.389--0.527)
                 18.5\~                                                                     1.000
                 24.0\~   1.008    0.031      1025.644   \<0.001                            2.741 (2.577--2.916)
                 30.0\~   1.233    0.063      379.395    \<0.001                            3.430 (3.030--3.883)
                                                         *p* value for trend *p* \< 0.001   
  Model I ^a^    \<18.5   −0.695   0.081      73.860     \<0.001                            0.499 (0.426--0.585)
                 18.5\~                                                                     1.000
                 24.0\~   0.951    0.032      865.523    \<0.001                            2.587 (2.428--2.756)
                 30.0\~   1.285    0.065      393.025    \<0.001                            3.614 (3.183--4.104)
                                                         *p* value for trend *p* \< 0.001   
  Model II ^b^   \<18.5   −0.316   0.086      13.337     \<0.001                            0.729 (0.616--0.864)
                 18.5\~                                                                     1.000
                 24.0\~   0.501    0.042      142.217    \<0.001                            1.651 (1.520--1.793)
                 30.0\~   0.539    0.083      42.235     \<0.001                            1.714 (1.457--2.017)
                                                         *p* value for trend *p* \< 0.001   

^a^ Adjusted age and gender; ^b^ Adjusted age, gender, region, district, ethnicity, education, marital status, main occupation, monthly family income per capita, smoking, drinking, exercise, central obesity, waist, hip; **^c^** B represents the logistics regression coefficient; **^d^** S.E. represents the standard error.
